TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bionomen AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
9,230
|
17,050
|
8,893 |
| Financial expenses |
6
|
6
|
6 |
| Earnings before taxes |
678
|
3,055
|
1,129 |
| EBITDA |
666
|
3,061
|
1,141 |
| Total assets |
4,264
|
5,043
|
3,235 |
| Current assets |
4,243
|
5,013
|
3,194 |
| Current liabilities |
720
|
1,029
|
1,786 |
| Equity capital |
3,280
|
3,750
|
1,339 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
76.9%
|
74.4%
|
41.4% |
| Turnover per employee |
4,615
|
8,525
|
4,446 |
| Profit as a percentage of turnover |
7.3%
|
17.9%
|
12.7% |
| Return on assets (ROA) |
16.0%
|
60.7%
|
35.1% |
| Current ratio |
589.3%
|
487.2%
|
178.8% |
| Return on equity (ROE) |
20.7%
|
81.5%
|
84.3% |
| Change turnover |
-7,820
|
8,157
|
962 |
| Change turnover % |
-46%
|
92%
|
12% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.